Influence of Intensified Medical Treatment and Organ Allocation on Outcome of Transplant Candidates

References

• 1 Hunt S A. 24^th Bethesda conference: cardiac transplantation.  J Am Coll Cardiol. 1993;  22 1-64
• 2 Deng M C, de Meester J MJ, Smits J MA. et al . Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity.  BMJ. 2000;  321 540-545
• 3 Stevenson L W, Hamilton M A, Tillisch I H. et al . Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens.  J Am Coll Cardiol. 1991;  12 159-172
• 4 Hosenpud J D, Leah E B, Keck B M. et al . The Registry of the international society for heart and lung transplantation: 17th official report - 2000.  J Heart Lung Transplant. 2000;  19 909-931
• 5 Stevenson W G, Stevenson L W, Middlekauff H R. Improving survival for patients with advanced heart failure: a study of 734 consecutive patients.  J Am Coll Cardiol. 1995;  26 1417-1423
• 6 Fonarow G C, Stevenson L W, Walden J A. et al . Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.  J Am Coll Cardiol. 1997;  30 725-732
• 7 Nagele H, Rodiger W. Sudden death and tailored medical therapy in elective candidates for heart transplantation.  J Heart Lung Transplant. 1999;  18 869-876
• 8 Hirt S W, Nitschke F P, Möller F. et al . Multizentrische Analyse der Effizienz eines regionalen Allokationsverbundes in der Herztransplantation.  Transplantationsmedizin. 2000;  12 31-36
• 9 Aaronson K D, Schwartz J S, Chen T MC. et al . Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.  Circulation. 1997;  95 2660-2667
• 10 MERIT-HF Study Group . Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).  Lancet. 1999;  353 2001-2007
• 11 CIBIS II Investigators and Committees . The Cardiac Insufficiency Bisoprolol Study II (CIBIS II).  Lancet. 1999;  353 9-13
• 12 Packer M, Bristow M R, Cohn J N. et al . (for the US Carvedilol Heart failure Study Group) The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure.  N Engl J Med. 1996;  334 1349-1355
• 13 Packer M, Coats A J, Fowler M B. et al . Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure.  N Engl J Med. 2001;  344 1651-1658